Illumina stock holds firm on its latest earnings base

Illumina Inc. (US4523271090) remains anchored by its last reported operating base, including $4.33 billion in revenue for fiscal 2025, a non-GAAP operating margin of 23.3% in Q4 2025, and adjusted diluted EPS of $4.58 for fiscal 2025. Those figures give Illumina stock a clear numerical frame even when the next market catalyst is not the main story.

Revenue and margin base

For fiscal 2025, Illumina reported $4.33 billion in revenue, which was down 1% from 2024. In the same period, non-GAAP operating margin reached 23.3% in Q4 2025, showing that profitability held up better than top-line growth.

Adjusted diluted EPS came in at $4.58 for fiscal 2025, which gives the share price a report-linked reference point for valuation. That combination of $4.33 billion revenue, 23.3% margin, and $4.58 EPS is the core published number set investors can use to track the stock.

What changed in 2025

Illumina also reported free cash flow of $1.03 billion for fiscal 2025, a level that matters because cash generation can soften the impact of slower revenue growth. The company said adjusted operating margin for full-year 2025 was 23.1%, close to the quarterly margin backdrop and a useful signpost for the business mix.

One comparison stands out: revenue fell 1% year over year, but free cash flow still reached $1.03 billion. That gap suggests the company entered 2026 with a more resilient cash profile than the sales line alone would imply.

Product line still matters

Sequencing platforms remain the commercial center of Illumina stock, because instrument placements and consumables drive most of the company. In a report-led day, that product mix is still the most relevant lens for how revenue, margin, and cash flow interact.

The base case for investors is straightforward: if consumables volume and installed-base utilization hold, the company can defend margin even before a new catalyst arrives. The published 2025 numbers already show why the market keeps focusing on operating discipline rather than just growth.

Stock reference point

The latest article body is built around disclosed 2025 report metrics, so the cleanest market reference is the companys own financial base rather than a live quote. Illumina stock therefore reads best through revenue, margin, EPS, and cash flow rather than a short-term price headline.

Read deeper into Illumina

The most useful follow-up is the companys latest reporting and product mix, because those two pieces explain how the 2025 numbers connect to the next trading setup. Investors tracking Illumina stock can compare future revenue and margin prints against the 2025 baseline of $4.33 billion revenue, 23.3% Q4 operating margin, and $1.03 billion free cash flow.

Illumina stock and sequencing tools

Illumina’s sequencing systems remain the product engine behind the companys reported revenue and cash generation. That makes the tools franchise important whenever investors revisit the 2025 figures and the 2026 setup.

Illumina stock closes on reported 2025 figures

Because no dated live quote is available in the source set, the most defensible closing reference is the companys reported 2025 financial profile. Illumina stock is framed here at $4.33 billion revenue, 23.3% Q4 2025 non-GAAP operating margin, $4.58 adjusted diluted EPS, and $1.03 billion free cash flow for fiscal 2025.